We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-5.41%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$284M
AUM Growth
-$92.7M
Cap. Flow
-$71.1M
Cap. Flow %
-25.08%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$56.4M
2
RNAC icon
Cartesian Therapeutics
RNAC
+$11.8M
3
CARM
Carisma Therapeutics
CARM
+$2.91M

Sector Composition

Rank Sector Weight
1 Healthcare 97.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
1
Seres Therapeutics
MCRB
$48.1M
$143M 50.54%
634,144
– –
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$77.3M 27.27%
480,666
– –
EDIT icon
3
Editas Medicine
EDIT
$399M
$56.7M 19.98%
3,376,184
– –
TTOO
4
DELISTED
T2 Biosystems, Inc
TTOO
$6.26M 2.21%
390
– –
AGIO icon
5
Agios Pharmaceuticals
AGIO
$2.16B
– –
-965,369
Closed -$56.4M
CARM
6
DELISTED
Carisma Therapeutics
CARM
– –
-66,201
Closed -$2.91M
RNAC icon
7
Cartesian Therapeutics
RNAC
$232M
– –
-27,562
Closed -$11.8M

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q2 2017 Portfolio in Review

As of Q2 2017, Flagship Pioneering held 7 positions worth $284M, down 25% from $376M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $71.1M in Q2 2017, closing 3 positions. Its most notable exit was Agios Pharmaceuticals, an estimated $56.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier.

  • Flagship Pioneering fully exited Agios Pharmaceuticals in Q2 2017, selling an estimated $56.4M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $284M portfolio in Q2 2017.
  • Flagship Pioneering opened 0 new positions and closed 3 in Q2 2017.
  • Flagship Pioneering's portfolio value fell 25% quarter-over-quarter to $284M.

Based on Flagship Pioneering's 13F filing for Q2 2017, filed 2 Aug 2017.